User profiles for "author:Mark A Berman"

Mark A. Berman

Chief Medical Officer, Better Therapeutics
Verified email at bettertx.com
Cited by 365

[HTML][HTML] Change in glycemic control with use of a digital therapeutic in adults with type 2 diabetes: cohort study

MA Berman, NL Guthrie, KL Edwards… - JMIR …, 2018 - diabetes.jmir.org
Background: Intensive lifestyle change can treat and even reverse type 2 diabetes. Digital
therapeutics have the potential to deliver lifestyle as medicine for diabetes at scale …

Randomized, controlled trial of a digital behavioral therapeutic application to improve glycemic control in adults with type 2 diabetes

J Hsia, NL Guthrie, P Lupinacci, A Gubbi… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE To evaluate the efficacy and safety of a digital therapeutic application (app)
delivering cognitive behavioral therapy (CBT) designed to improve glycemic control in …

[HTML][HTML] Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: health economic analysis

RJ Nordyke, K Appelbaum, MA Berman - Journal of medical Internet …, 2019 - jmir.org
Background Behavioral interventions can meaningfully improve cardiometabolic conditions.
Digital therapeutics (DTxs) delivering these interventions may provide benefits comparable …

Emergence of digital biomarkers to predict and modify treatment efficacy: machine learning study

NL Guthrie, J Carpenter, KL Edwards, KJ Appelbaum… - Bmj Open, 2019 - bmjopen.bmj.com
Objectives Development of digital biomarkers to predict treatment response to a digital
behavioural intervention. Design Machine learning using random forest classifiers on data …

[HTML][HTML] Achieving rapid blood pressure control with digital therapeutics: retrospective cohort and machine learning study

NL Guthrie, MA Berman, KL Edwards, KJ Appelbaum… - JMIR cardio, 2019 - cardio.jmir.org
Background: Behavioral therapies, such as electronic counseling and self-monitoring
dispensed through mobile apps, have been shown to improve blood pressure, but the …

[HTML][HTML] Cost-effectiveness analysis of a prescription digital therapeutic in type 2 diabetes

NJ Davison, NL Guthrie, S Medland, P Lupinacci… - Advances in …, 2024 - Springer
Methods We modeled the T2D pathway using an individual patient-level simulation; clinical
data were sourced from the intention-to-treat subset of the BT-001 randomized clinical trial …

Cognitive behavioral therapy delivered via digital mobile application for the treatment of type 2 diabetes: rationale, design, and baseline characteristics of a …

ME Canonico, J Hsia, NL Guthrie… - Clinical …, 2022 - Wiley Online Library
Background The prevalence of type 2 diabetes (T2D) continues to rise in the United States
and worldwide. Cognitive behavioral therapy (CBT) has been shown to improve glycemic …

Kosher fraud statutes and the establishment clause: are they kosher

MA Berman - Colum. JL & Soc. Probs., 1992 - HeinOnline
The religious ritual most commonly associated with Judaism is the peculiar dietary laws
many Jews observe. These laws of" kashrut" delineate the foods a Jew is permitted to eat …

An inventor's perspective on consumer health informatics

A Bosworth, C York, H Kotansky, MA Berman - American journal of …, 2011 - Elsevier
Healthcare providers have less time to help pa-tients make the lifestyle changes required to
minimize their risk of a serious disease—such as cancer, heart disease, and diabetes—or …

SAT-LB120 a software application delivering behavioral therapy improved glycemic control in adults with type 2 diabetes

NL Guthrie, KJ Appelbaum… - Journal of the Endocrine …, 2020 - academic.oup.com
Despite advances in pharmacological treatment, half of US patients with type 2 diabetes are
not achieving glycemic control (1). Even when glycemic control is achieved via …